Breast cancer risk accumulation starts early: prevention must also Graham A. ColditzKari BohlkeCatherine S. Berkey Review 13 May 2014 Pages: 567 - 579
The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines Azadeh MotevalliHemad YasaeiTerry Roberts Preclinical Study Open access 08 May 2014 Pages: 581 - 591
Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators Lyndsay V. RhodesChandra R. TateBridgette M. Collins-Burow Preclinical study 09 May 2014 Pages: 593 - 604
T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands Pinar KarasarGunes Esendagli Preclinical study 10 May 2014 Pages: 605 - 614
Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer Hee Jin LeeIn Ah ParkGyungyub Gong Preclinical study 13 May 2014 Pages: 615 - 623
Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families Angela G. ArnoldEbunoluwa OtegbeyeLiying Zhang Preclinical study 14 May 2014 Pages: 625 - 634
Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups Wai Jin TanJohnathan C. LaiPuay Hoon Tan Preclinical study 16 May 2014 Pages: 635 - 645
Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues Nilasha BanerjeeNaomi MillerReina Bendayan Preclinical study 16 May 2014 Pages: 647 - 661
MRI breast screening in high-risk women: cancer detection and survival analysis Evans D. GarethKesavan NishaDuffy Stephen Clinical trial 01 April 2014 Pages: 663 - 672
Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors Inge A. P. Derks-SmeetsChristine E. M. de Die-SmuldersWillem M. Verpoest Clinical trial 19 April 2014 Pages: 673 - 681
Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial Melissa V. HansenLærke T. AndersenIsmail Gögenur Clinical trial 23 April 2014 Pages: 683 - 695
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms C. A. DrukkerM. V. NijenhuisS. C. Linn Clinical Trial Open access 24 April 2014 Pages: 697 - 705
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing Priyanka SharmaJennifer R. KlempAndrew K. Godwin Clinical trial 07 May 2014 Pages: 707 - 714
Adolescent physical activity in relation to breast cancer risk Caroline E. BoekeA. Heather EliassenRulla M. Tamimi Epidemiology 30 March 2014 Pages: 715 - 724
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer Denise A. YardleyPeter A. KaufmanDebu Tripathy Epidemiology Open access 06 April 2014 Pages: 725 - 734
Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study Patrick T. BradshawJoseph G. IbrahimMarilie D. Gammon Epidemiology 01 May 2014 Pages: 735 - 742
Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer Katherine E. Reeder-HayesAnne Marie MeyerStephanie B. Wheeler Epidemiology 01 May 2014 Pages: 743 - 751
Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010–2011) Helmneh M. SineshawMia GaudetAhmedin Jemal Epidemiology 03 May 2014 Pages: 753 - 763
Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast Nehmat HoussamiLinn A. AbrahamDiana L. Miglioretti Epidemiology 07 May 2014 Pages: 765 - 773
Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan Muhammad U. RashidNoor MuhammadUte Hamann Epidemiology 07 May 2014 Pages: 775 - 784
Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes Chin-Hsiao Tseng Epidemiology 11 May 2014 Pages: 785 - 790
Microsatellite genotyping reveals a signature in breast cancer exomes L. J. McIverN. C. FonvilleH. R. Garner Brief Report Open access 17 May 2014 Pages: 791 - 798
